Cks. Chao et al., RADIATION-THERAPY FOR PRIMARY ORBITAL LYMPHOMA, International journal of radiation oncology, biology, physics, 31(4), 1995, pp. 929-934
Citations number
29
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: The influence of tumor size, grade, thoroughness of staging w
orkup, and radiation dose on disease control, radiation-related compli
cations, and incidence of systemic progression of primary orbital lymp
homa is analyzed. Methods and Materials: Twenty patients with Stage I
primary orbital lymphoma were treated from August 1976 through August
1991 at Mallinckrodt Institute of Radiology, Staging workups included
physical examination, chest x-ray, complete blood count (CBC), liver f
unction test, and computerized tomography (CT) scan of the orbit, abdo
men, and pelvis. Nineteen patients had bone marrow biopsy. The histolo
gical types based on the National Cancer Institute working formulation
were 9 low-grade and 11 intermediate-grade, including five lymphocyti
c lymphomas of intermediate differentiation. The extension of disease
and the volume of tumor were evaluated by CT scan of the orbit. The mo
st commonly used radiation therapy technique was single anterior direc
t field with 4 MV or 6 MV photons. Lens was shielded or not treated in
eight patients. Dose ranged from 20 to 43.2 Gy. Thirteen of 20 patien
ts received 30 Gy. Minimum follow-up was 24 months (median, 4 years).
Results: Local control was achieved in all 20 patients. One patient wi
th lymphocytic lymphoma with intermediate differentiation developed di
sseminated disease. Actuarial disease-free survival (DFS) was 100% and
90% at 2 and 5 years, respectively. No retinopathy was observed. Cata
racts were noted in seven patients at 1 to 10 years following irradiat
ion (median, 2 years). Three patients developed lacrimal function diso
rder; however, no corneal ulceration occured. Conclusions: Thirty Gy i
n 15 fractions appears to be a sufficient dose for local control with
acceptable morbidity, especially for low-grade, as well as certain typ
es of intermediate-grade lymphomas, such as diffuse small cleaved cell
and lymphocytic lymphoma of intermediate differentiation. Systemic di
ssemination is minimal, provided local control is achieved and initial
staging workups are adequate.